Publicaciones en colaboración con investigadores/as de University of Antwerp (1)

2016

  1. Aflibercept plus FOLFIRI for 2nd line treatment of metastatic colorectal cancer (mCRC): Long-term safety observation from the global aflibercept safety and quality-of-life (QoL) program (ASQoP)

    Annals of Oncology, Vol. 27, pp. vi182